Terms: = Uterine cancer AND TOP2A, TOP2, TP2A AND Prognosis
14 results:
1. HPV16 E6 promoting cervical cancer progression through down-regulation of miR-320a to increase top2a expression.
Zhang J; Yu X; Guo Y; Wang D
Cancer Med; 2024 Feb; 13(3):e6875. PubMed ID: 38205938
[TBL] [Abstract] [Full Text] [Related]
2. [Expression of ProEXC and PRMT5 in cervical adenocarcinoma and their clinical significance].
Cui HX; Lou XL; Xia W; Zhang YS; Cheng XY; Deng LF
Zhonghua Yi Xue Za Zhi; 2023 Dec; 103(48):3967-3971. PubMed ID: 38129175
[TBL] [Abstract] [Full Text] [Related]
3. Bioinformatics and cheminformatics approaches to identify pathways, molecular mechanisms and drug substances related to genetic basis of cervical cancer.
Andalib KMS; Rahman MH; Habib A
J Biomol Struct Dyn; 2023; 41(23):14232-14247. PubMed ID: 36852684
[TBL] [Abstract] [Full Text] [Related]
4. Bioinformatics Screening of Potential Biomarkers from mRNA Expression Profiles to Discover Drug Targets and Agents for Cervical cancer.
Reza MS; Harun-Or-Roshid M; Islam MA; Hossen MA; Hossain MT; Feng S; Xi W; Mollah MNH; Wei Y
Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409328
[TBL] [Abstract] [Full Text] [Related]
5. Expression analysis of p16 and top2a protein biomarkers in cervical cancer lesions and their correlation with clinico-histopathological characteristics in a referral hospital, Tanzania.
Zuberi Z; Mremi A; Chilongola JO; Semango G; Sauli E
PLoS One; 2021; 16(10):e0259096. PubMed ID: 34705880
[TBL] [Abstract] [Full Text] [Related]
6. DFF40 deficiency in cancerous T cells is implicated in chemotherapy drug sensitivity and resistance through the regulation of the apoptotic pathway.
Kulbay M; Johnson B; Fiola S; Diaz RJ; Bernier J
Biochem Pharmacol; 2021 Dec; 194():114801. PubMed ID: 34678222
[TBL] [Abstract] [Full Text] [Related]
7. Screening and Discovery of New Potential Biomarkers and Small Molecule Drugs for Cervical cancer: A Bioinformatics Analysis.
Qiu HZ; Huang J; Xiang CC; Li R; Zuo ED; Zhang Y; Shan L; Cheng X
Technol Cancer Res Treat; 2020; 19():1533033820980112. PubMed ID: 33302814
[TBL] [Abstract] [Full Text] [Related]
8. top2a and CENPF are synergistic master regulators activated in cervical cancer.
Yu B; Chen L; Zhang W; Li Y; Zhang Y; Gao Y; Teng X; Zou L; Wang Q; Jia H; Liu X; Zheng H; Hou P; Yu H; Sun Y; Zhang Z; Zhang P; Zhang L
BMC Med Genomics; 2020 Oct; 13(1):145. PubMed ID: 33023625
[TBL] [Abstract] [Full Text] [Related]
9. Integrated analysis of key microRNAs /TFs /mRNAs/ in HPV-positive cervical cancer based on microRNA sequencing and bioinformatics analysis.
Yuan Y; Shi X; Li B; Peng M; Zhu T; Lv G; Liu L; Jin H; Li L; Qin D
Pathol Res Pract; 2020 Jun; 216(6):152952. PubMed ID: 32307200
[TBL] [Abstract] [Full Text] [Related]
10. Identification of key genes and pathways of diagnosis and prognosis in cervical cancer by bioinformatics analysis.
Yang HJ; Xue JM; Li J; Wan LH; Zhu YX
Mol Genet Genomic Med; 2020 Jun; 8(6):e1200. PubMed ID: 32181600
[TBL] [Abstract] [Full Text] [Related]
11. Identification of a novel diagnostic gene expression signature to discriminate uterine leiomyoma from leiomyosarcoma.
Adams CL; Dimitrova I; Post MD; Gibson L; Spillman MA; Behbakht K; Bradford AP
Exp Mol Pathol; 2019 Oct; 110():104284. PubMed ID: 31301306
[TBL] [Abstract] [Full Text] [Related]
12. Associations between epidermal growth factor receptor and topoisomerase II-alpha gene copy number variations, human papillomavirus positivity, and cytologic analysis in cervical cell lesions.
Kaya I; Sivrikoz ON; Etlik Ö; Gök A
Indian J Pathol Microbiol; 2017; 60(3):328-335. PubMed ID: 28937367
[TBL] [Abstract] [Full Text] [Related]
13. Evaluation of top2a as a Predictive Marker for Endometrial cancer With Taxane-Containing Adjuvant Chemotherapy.
Ito F; Furukawa N; Nakai T
Int J Gynecol Cancer; 2016 Feb; 26(2):325-30. PubMed ID: 26588239
[TBL] [Abstract] [Full Text] [Related]
14. HER2-positive endometrial cancer subtype carries poor prognosis.
Lapińska-Szumczyk S; Supernat A; Majewska H; Gulczyński J; Luczak A; Biernat W; Wydra D; Zaczek AJ
Clin Transl Sci; 2014 Dec; 7(6):482-8. PubMed ID: 25201050
[TBL] [Abstract] [Full Text] [Related]